{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:59:13Z","timestamp":1790207953648,"version":"4.1.0"},"reference-count":34,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY029594"],"award-info":[{"award-number":["R01 EY029594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013884","name":"Macula Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013884","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005426","name":"Association for Research in Vision and Ophthalmology","doi-asserted-by":"publisher","award":["Mallinckrodt Young Investigator Grant"],"award-info":[{"award-number":["Mallinckrodt Young Investigator Grant"]}],"id":[{"id":"10.13039\/100005426","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stanley M Truhlsen Family Foundation, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Ophthalmology"],"published-print":{"date-parts":[[2022,5,4]]},"DOI":"10.1080\/17469899.2022.2114456","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T11:59:42Z","timestamp":1660823982000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Triamcinolone acetonide injectable suspension for suprachoroidal use in the treatment of macular edema associated with uveitis"],"prefix":"10.1080","volume":"17","author":[{"given":"Joanne","family":"Thomas","sequence":"first","affiliation":[{"name":"Medical College of Georgia, August University, Augusta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Kim","sequence":"additional","affiliation":[{"name":"Truhlsen Eye Institute, Department of Ophthalmology, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Albini","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5417-7771","authenticated-orcid":false,"given":"Steven","family":"Yeh","sequence":"additional","affiliation":[{"name":"Truhlsen Eye Institute, Department of Ophthalmology, University of Nebraska Medical Center, Omaha, NE, USA"},{"name":"Department of Ophthalmology, Emory Eye Center, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,8,21]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2016.1196713"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2016.3229"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.17925\/USOR.2020.13.2.76"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.115"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S180580"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.7.603"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13702"},{"key":"cit0008","unstructured":"Xipere (triamcinolone acetonide injectable suspension) [package insert]. Alpharetta (GA); Clearside Biomedical, Inc. 2021."},{"key":"cit0009","first-page":"41","volume":"3","author":"Couch SM","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"cit0010","first-page":"221","volume-title":"Retinal pharmacotherapy","author":"C\u00e1ceres-del-Carpio J","year":"2010"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2007.06.004"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.08.021"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2016.12.008"},{"issue":"6","key":"cit0014","first-page":"459","volume":"8","author":"Muya L","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"cit0015","first-page":"233","volume":"30","author":"Emi K","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.02.021"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11747"},{"issue":"15","key":"cit0018","first-page":"5063","volume":"54","author":"Edelhauser HF","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.5.6.14"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002279"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.01.006"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14024"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1954199"},{"issue":"8","key":"cit0024","first-page":"1139","volume":"106","author":"Khurana RN","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-318019"},{"key":"cit0026","unstructured":"Triesence (triamcinolone acetonide injectable suspension) [package insert]. Fort Worth (TX); Alcon Labaratories, Inc; 2007"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-20030901-08"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20180831-07"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2020.08.007"},{"key":"cit0030","unstructured":"Phase 2 trial to evaluate safety and efficacy of AU-011 via suprachoroidal administration in subjects with primary indeterminate lesions and small choroidal melanoma. [cited 2022 Aug 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04417530"},{"key":"cit0031","unstructured":"REGENXBIO. RGX-314 RegenXBio.com2021 [2022 Jan 1]."},{"key":"cit0032","unstructured":"RGX-314 gene therapy administered in the suprachoroidal space for participants with neovascular age-related macular degeneration (nAMD) (AAVIATE). [cited 2022 Aug 5]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04514653"},{"key":"cit0033","unstructured":"REGENXBIO. Regenxbio presents additional positive interim data from trials of RGX-314 in wet AMD and diabetic retinopathy using suprachoroidal delivery at AAO 2021 (News Release, 2021 Nov 12."},{"key":"cit0034","unstructured":"RGX-314 dene therapy administered in the suprachoroidal space for participants with diabetic retinopathy (DR) without center involved-diabetic macular edema (CI-DME) (ALTITUDE). [cited 2022 Aug 5]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04567550"}],"container-title":["Expert Review of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17469899.2022.2114456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T11:35:03Z","timestamp":1677497703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17469899.2022.2114456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5,4]]}},"alternative-id":["10.1080\/17469899.2022.2114456"],"URL":"https:\/\/doi.org\/10.1080\/17469899.2022.2114456","relation":{},"ISSN":["1746-9899","1746-9902"],"issn-type":[{"value":"1746-9899","type":"print"},{"value":"1746-9902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierl20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierl20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}